PART 2 The following note appeared in the ADA Research Notebook of a
1998 issue of Diabetes Forecast: There's a new drug for type 2 diabetes on the horizon: BTS 67-582. Like
sulfonylureas, BTS 67-582 spurs the pancreas to release more insulin,
but it does this in different way than sulfonylureas do. (It affects different
binding sites on the islet cells.) In a recent study, researchers found
BTS 67-582 is safe and effective in controlling type 2 diabetes. They
have also narrowed the search for the most effective and safe dosage... A. (10 points) How does BTS 67-582 work? Hypothesize a reasonable mechanism
for its action.
|